1,1-Dicyclohexyl-3-(4-bromomethyl-thiazol-2-yl)urea → 1,1-Dicyclohexyl-3-[4-(pyridin-2-ylsulfanylmethyl)-thiazol-2-yl]urea
반응식
[CH:1]1([N:7]([CH:18]2[CH2:23][CH2:22][CH2:21][CH2:20][CH2:19]2)[C:8]([NH:10][C:11]2[S:12][CH:13]=[C:14]([CH2:16]Br)[N:15]=2)=[O:9])[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.[SH:24][C:25]1[CH:30]=[CH:29][CH:28]=[CH:27][N:26]=1>>[CH:1]1([N:7]([CH:18]2[CH2:23][CH2:22][CH2:21][CH2:20][CH2:19]2)[C:8]([NH:10][C:11]2[S:12][CH:13]=[C:14]([CH2:16][S:24][C:25]3[CH:30]=[CH:29][CH:28]=[CH:27][N:26]=3)[N:15]=2)=[O:9])[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1참가 물질
3
실험 절차
Prepared as described in general procedure (L) from 1,1-dicyclohexyl-3-(4-bromomethyl-thiazol-2-yl)urea and 2-mercaptopyridine.
후처리
- customPrepared
출처 및 근거
- ORD 기록
- ord-d8db3587529e4a93a3f4c993e5aae0f1
- 출처 데이터셋
- uspto-grants-2009_10
- 특허 번호
- US07598391B2
반응 노트
불러오는 중…